DALLAS, Jan. 25, 2012 /PRNewswire/ -- Goldfarb Branham
LLP is investigating whether the board of directors of Chemed
Corporation (NYSE: CHE) violated shareholder protection laws by
fraudulently billing the government through Medicare. Concerned
Chemed investors who purchased before or between February 15, 2010 and November 16, 2011 are encouraged to contact
attorney Hamilton Lindley at 877-583-2855 or
hlindley@goldfarbbranham.com about their rights and remedies.
"In November, a whistleblower accused Chemed of defrauding the
federal government by conspiring with health insurers to enroll
Medicare patients who were not dying in hospice," securities lawyer
Hamilton Lindley said. "The Department of Justice is also
investigating potentially fraudulent conduct into a company
subsidiary. Our proposed lawsuit will ensure that proper controls
are placed to correct improper behavior and to maximize the
company's profitability for investors."
Goldfarb Branham LLP lawyers have significant experience
representing shareholders and whistleblowers in securities lawsuits
nationwide. Chemed shareholders – or anyone with knowledge about
this situation – should contact lawyer Hamilton Lindley at
hlindley@goldfarbbranham.com or 877-583-2855.
Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
hlindley@goldfarbbranham.com
www.goldfarbbranham.com
SOURCE Goldfarb Branham LLP